Detail
| LncRNA Name | LUNAR1 |
| Synonyms | LUNAR1 |
| Region | GRCh38_15:99014704-99031050 Sequence |
| Ensembl | NA |
| RefSeq | NR_126487 |
| Circulating | ✘ |
| Drug-resisitant | ✘ |
| Prognostic | ✔ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | diffuse large B-cell lymphoma |
| ICD-0-3 | M9680/3 |
| Methods | qPCR, RNAi, Western blot, Flow cytometry assay, MTT assay etc. |
| Sample | lymph node, cell lines (OCI-LY-3, OCI-LY-7, OCI-LY-10, SU-DHL-4, SU-DHL-6 and RCK-8) |
| Expression Pattern | up-regulated |
| Function Description | LUNAR1 in tumor was significantly higher the normal. In cancerous tissues, LUNAR1 expression was at a level higher than that of normal specimens, with the median level of 0.756 compared with normal counterparts. The higher expression of LUNAR1 was significantly correlated with stage, rituximab and IPI. Further experiments revealed that LUNAR1 knockdown significantly repressed cell proliferation of DLBCL by regulating E2F1, cyclin D1 and p21. |
| Pubmed ID | 26796267 |
| Year | 2016 |
| Title | Long noncoding RNA LUNAR1 associates with cell proliferation and predicts a poor prognosis in diffuse large B-cell lymphoma. |
| External Links |
| Links for LUNAR1 | GenBank HGNC lncrnadb Noncode |
| Links for diffuse large B-cell lymphoma | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.